Crowell, P. D., Giafaglione, J. M., Jones, A. E., Nunley, N. M., Hashimoto, T., Delcourt, A. M., . . . Goldstein, A. S. (2023). MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Elsevier.
Chicago-viite (17. p.)Crowell, Preston D., et al. MYC Is a Regulator of Androgen Receptor Inhibition-induced Metabolic Requirements in Prostate Cancer. Elsevier, 2023.
MLA-viite (9. p.)Crowell, Preston D., et al. MYC Is a Regulator of Androgen Receptor Inhibition-induced Metabolic Requirements in Prostate Cancer. Elsevier, 2023.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.